230 related articles for article (PubMed ID: 35846794)
21. Neuropilin1 Expression Acts as a Prognostic Marker in Stomach Adenocarcinoma by Predicting the Infiltration of Treg Cells and M2 Macrophages.
Kang JY; Gil M; Kim KE
J Clin Med; 2020 May; 9(5):. PubMed ID: 32408477
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinoma.
Huang Z; He A; Wang J; Lu H; Xu X; Zhang R; Liao W; Feng Q; Wu L
Cancer Biomark; 2022; 34(1):77-93. PubMed ID: 34657879
[TBL] [Abstract][Full Text] [Related]
23. Increased
Zhaoran S; Linnebacher CS; Linnebacher M
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
[TBL] [Abstract][Full Text] [Related]
24. Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma.
Zhu D; Wu S; Li Y; Zhang Y; Chen J; Ma J; Cao L; Lyu Z; Hou T
Cancer Cell Int; 2022 Mar; 22(1):124. PubMed ID: 35305616
[TBL] [Abstract][Full Text] [Related]
25. Prognostic and immunological role of Fam20C in pan-cancer.
Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
[TBL] [Abstract][Full Text] [Related]
26. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
27. Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD.
Wang Z; Tian Z; Song X; Zhang J
BMC Immunol; 2022 Jan; 23(1):1. PubMed ID: 34998385
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer.
Liu Q; Jiang J; Zhang X; Zhang M; Fu Y
Front Oncol; 2021; 11():723131. PubMed ID: 34745945
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells.
Wei L; Wu X; Wang L; Chen L; Wu X; Song T; Wang Y; Chang W; Guo A; Niu Y; Huang H
BMC Cancer; 2024 Jan; 24(1):15. PubMed ID: 38166744
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma.
Huang Z; Lai H; Liao J; Cai J; Li B; Meng L; Wang W; Mo X; Qin H
Front Oncol; 2021; 11():729230. PubMed ID: 34604068
[TBL] [Abstract][Full Text] [Related]
32. Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma.
Zhu YZ; Liao XW; Yin W; Wei HM
Int J Gen Med; 2022; 15():1131-1146. PubMed ID: 35153505
[TBL] [Abstract][Full Text] [Related]
33. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
[TBL] [Abstract][Full Text] [Related]
34. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
Zhou F; Lin Q; Zheng Z
Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma.
Zhou X; Nie H; Wang C; Yu X; Yang X; He X; Ou C
J Cancer; 2024; 15(10):3154-3172. PubMed ID: 38706902
[TBL] [Abstract][Full Text] [Related]
36. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
37. Gelsolin Can Be a Prognostic Biomarker and Correlated with Immune Infiltrates in Gastric Cancer.
Wu Y; Zheng J; Yan Y; Liu J; Zhou Y
Int J Gen Med; 2022; 15():927-936. PubMed ID: 35115818
[TBL] [Abstract][Full Text] [Related]
38. Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance.
Huang L; Irshad S; Sultana U; Ali S; Jamil A; Zubair A; Sultan R; Abdel-Maksoud MA; Mubarak A; Almunqedhi BM; Almanaa TN; Malik A; Alamri A; Kodous AS; Mares M; Zaky MY; Saba Sajjad S; Hameed Y
Am J Transl Res; 2024; 16(3):873-888. PubMed ID: 38586106
[TBL] [Abstract][Full Text] [Related]
39. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
Li D; Chen B; Zeng Y; Wang H
Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors.
Liu D; Wang X; Shi E; Wang L; Nie M; Li L; Jiang Q; Kong P; Shi S; Wang C; Yan S; Qin Z; Zhao S
Front Genet; 2021; 12():699910. PubMed ID: 34335697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]